Navigation Links
Two Indians on Team to Battle Cervical Cancer

A US-based team, with two Indians on board, has won $100,000 in funding at the Duke University's CUREs competition to develop a device to facilitate// cervical cancer prevention in poorer parts of the planet.

The device, cerviScope, is a portable colposcope - an electric microscope that gives an illuminated and enlarged view of the cervix, that will cost roughly 95 percent less than comparable technology in US-based hospitals. Since it is portable, it can be transported in mobile hospital units to benefit patients in remote areas.

This year's five-member winning team included Gauravjit Singh (Chandigarh) and Ramakrishnan "Ram" Balasubramanian (Mumbai). Other members of the team were Teh Tam (US citizen of Chinese origin), Xiao Wu of Hong Kong and Adnan Haider from Karachi in Pakistan.

Cervical cancer is the leading cause of cancer-related death among women. Over 260,000 women die every year from this disease, with 80 percent of these cases occurring in the "developing world".

Cervical cancer is highly preventable, but this problem is overlooked by most public health organizations.

"ImaGyn has garnered resounding support from the gynaecology community in Duke Hospital and in Hopital St. Croix in Haiti during the development of the cerviScope," said a university statement.

During an early prototype demonstration, Peter Cartwright proclaimed: "I think it's got some potential. (The cerviScope) is much better actually than the colposcope... considering the social impact on women in the developing world, I would pay $1,000 to sponsor one or more cerviScopes for use in a low-resource country like Haiti."

This new device could have a price edge over the $10,000 colposcope.

Jeffrey Wilkinson of Urogynecology, Duke University School of Medicine, was quoted as saying: "...I think it is a great idea. I have personally seen the value of colposcopes in resource-poor settings in India,
'"/>




Page: 1 2

Related medicine news :

1. Heart attack kills one in every 10 Indians
2. Are Indians aware of SARS ?
3. Indians Stay Away from Coke, Pepsi After Toxin Scare
4. Indians Are More Prone To Lifestyle Diseases
5. Dental health neglected by over 60 % of Indians
6. Indians are certainly having their greens and eating them too!
7. An Estimated 150 Million Indians Suffer From Arthritis
8. Debra Winger Wants Indians Abroad To Help Visually Impaired
9. More Than 50 Percent Indians Aged Over 40 Have Diabetes, High Blood Pressure
10. Indians in Gulf to Get More Education Facilities
11. Lakhs of Indians Exposed to High Levels of Poisonous Gases
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two Indians Team Battle Cervical Cancer

Other Medicine News:Health News:Complimentary White Paper: Where Senior Care Suppliers Spent Marketing and PR Dollars in 2007 and 2008 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 3Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 4Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 5Health News:Beware of Ten Mistakes after Social Security Denies Disability Benefits 2Health News:Beware of Ten Mistakes after Social Security Denies Disability Benefits 3Health News:Beware of Ten Mistakes after Social Security Denies Disability Benefits 4Health News:Beware of Ten Mistakes after Social Security Denies Disability Benefits 5Health News:Beware of Ten Mistakes after Social Security Denies Disability Benefits 6Health News:Can your doctor correctly read a critical heart test? 2Health News:Can your doctor correctly read a critical heart test? 3Health News:Health Market Science, Inc. Ranked Number 17 in Deloitte's Fast 50 Program for Greater Philadelphia 2Health News:Health Market Science, Inc. Ranked Number 17 in Deloitte's Fast 50 Program for Greater Philadelphia 3
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Promising device snags young inventors coveted spot at IShow 8813 1Promising device snags young inventors coveted spot at IShow 8813 2Promising device snags young inventors coveted spot at IShow 8813 3Cogdell Spencer Inc Declares Quarterly Dividend 48744 1Cogdell Spencer Inc Declares Quarterly Dividend 48744 2New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 1New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 2New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 3New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 4New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 5